BrainsWay Ltd. (BWAY) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights
March 15, 2023 7:30 AM EDTBURLINGTON, Mass. and JERUSALEM, March 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a world leader in advanced and non-invasive treatment for brain disorders, today reported fourth quarter and full-year 2022 financial results and provided an operational update.
Recent Financial and Operational Highlights
For the three months ended December 31, 2022, revenues were $6.0 million, a 29% decrease as compared to the prior year period.As of December 31, 2022, BrainsWays Deep TMS installed base was 884 total systems, a 17%... More


